Skip to main navigation
Skip to search
Skip to main content
UNIC | Research Portal Home
Home
Profiles
Research units
Research output
Projects
Search by expertise, name or affiliation
Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial
Henrik Gonzalez
, Katharina Stibrant Sunnerhagen
, Inger Sjöberg
,
Georgios Kaponides
, Tomas Olsson
, Kristian Borg
Medical School
Karolinska Institutet
University of Gothenburg
Uppsala University
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Post-polio Syndrome
100%
Randomized Controlled Trial
100%
Intravenous Immunoglobulin (IVIg)
100%
Muscle Strength
66%
Sleep Quality
33%
MFI-20
33%
Treatment Group
33%
Activity Scale
33%
Placebo
33%
SF-36 Questionnaire
33%
Timed-up-and-go
33%
6-minute Walk Test (6MWT)
33%
Physical Activity
33%
Inflammatory Cytokines
16%
Between-group
16%
Quality of Life
16%
Immunosuppressive Therapy
16%
New Symptoms
16%
Consecutive Days
16%
Outcome Test
16%
Treatment Options
16%
Visual Analog Pain Scale
16%
Active Treatment
16%
Randomized Double-blind Placebo-controlled Study
16%
Placebo Groups
16%
Visual Analog Scale
16%
Survivors
16%
Dosing Schedule
16%
Short Form 36 (SF-36)
16%
Poliomyelitis
16%
Supportive Treatment
16%
Inflammatory Process
16%
University Clinic
16%
Intervention Group
16%
Multidimensional Fatigue Inventory
16%
Test Quality
16%
Acute Infection
16%
Neuroscience
Post-Polio Syndrome
100%
Medicine and Dentistry
Post-Polio Syndrome
100%
Pharmacology, Toxicology and Pharmaceutical Science
Post-Polio Syndrome
100%